Legislation: batch B — IL IN KS KY LA MA MD ME MI MN

Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>

legislation/us/states/md/2026/sb-778.md

@@ -0,0 +1,70 @@
+---
+type: "Bill"
+title: "Clinical Research Pharmacies and Clinical Trials - Permits and Ownership"
+description: "Clinical Research Pharmacies and Clinical Trials - Permits and Ownership"
+jurisdiction: "us/states/md"
+legislature: "Maryland General Assembly"
+session: "2026"
+identifier: "SB 778"
+citation: "Maryland SB 778 (2026)"
+classification: ["bill"]
+subjects: []
+status: "enacted"
+primary_sponsors: ["Feldman"]
+version_count: 3
+action_count: 13
+vote_count: 2
+first_action: "2026-02-06"
+last_action: "2026-04-28"
+source: "openstates"
+source_identifier: "ocd-bill/498ecf74-d8cc-4270-abfc-89c1610eec22"
+source_url: "http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/sb0778?ys=2026RS"
+source_hash: "8cf325508ecdbe9edac924f7ec2711b1651a9ee5b2b4ac3c76dfbbb206244967"
+vintage: "2026-07-01"
+source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
+retrieved_at: "2026-07-06"
+confidence: "reported"
+tags: ["legislation", "bill", "us-md"]
+---
+
+# Maryland SB 778 (2026) — Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
+
+## Version chain
+
+The bill's text revisions, in order — the diff chain from filing to enrollment.
+
+1. **Chapter - Clinical Research Pharmacies and Clinical Trials - Permits and Ownership** (committee substitute) — [source](http://mgaleg.maryland.gov/2026RS/Chapters_noln/CH_206_sb0778t.pdf)
+2. **First - Clinical Research Pharmacies and Clinical Trials - Permits, Ownership, and Definition of Practice of Medicine** (committee substitute) — [source](http://mgaleg.maryland.gov/2026RS/bills/sb/sb0778f.pdf)
+3. **Third - Clinical Research Pharmacies and Clinical Trials - Permits and Ownership** (committee substitute) — [source](http://mgaleg.maryland.gov/2026RS/bills/sb/sb0778t.pdf)
+
+## Votes
+
+- On Third Reading — **129–6** (pass) · lower
+- On Third Reading — **42–0** (pass) · upper
+
+## Sponsors
+
+- Feldman — primary (person)
+
+## Timeline
+
+The legislative action history — every referral, reading, and vote.
+
+- **2026-02-06** First Reading Finance `referral-committee`
+- **2026-02-12** Hearing 3/03 at 1:00 p.m.
+- **2026-03-19** Favorable with Amendments Report by Finance `committee-passage-favorable`
+- **2026-03-19** Favorable with Amendments { `committee-passage-favorable`
+- **2026-03-19** Second Reading Passed with Amendments
+- **2026-03-20** Third Reading Passed `passage`
+- **2026-03-21** Referred Health `referral-committee`
+- **2026-03-25** Hearing 4/02 at 1:00 p.m.
+- **2026-04-11** Favorable Report by Health `committee-passage-favorable`
+- **2026-04-11** Favorable Adopted Second Reading Passed `committee-passage-favorable`
+- **2026-04-13** Third Reading Passed `passage`
+- **2026-04-13** Returned Passed
+- **2026-04-28** Approved by the Governor - Chapter 206 `executive-signature`
+
+## Source
+
+OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/498ecf74-d8cc-4270-abfc-89c1610eec22`. Confidence: reported (aggregated from official Maryland legislature records).
+